Alcon Inc. (ALC)
NYSE: ALC · Real-Time Price · USD
85.45
+1.33 (1.58%)
At close: Aug 7, 2025, 4:00 PM
85.37
-0.08 (-0.09%)
Pre-market: Aug 8, 2025, 7:26 AM EDT
Verve Therapeutics Market Cap
Alcon has a market cap or net worth of $42.15 billion as of August 8, 2025. Its market cap has decreased by -5.26% in one year.
Market Cap
42.15B
Enterprise Value
46.32B
1-Year Change
-5.26%
Ranking
Category
Stock Price
$85.45
Market Cap Chart
Since April 9, 2019, Alcon's market cap has increased from $28.35B to $42.15B, an increase of 48.68%. That is a compound annual growth rate of 6.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2025 | 42.15B | 0.51% |
| Dec 30, 2024 | 41.93B | 9.07% |
| Dec 29, 2023 | 38.45B | 14.43% |
| Dec 30, 2022 | 33.60B | -22.39% |
| Dec 30, 2021 | 43.29B | 30.98% |
| Dec 30, 2020 | 33.05B | 18.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 575.32B |
| Johnson & Johnson | 413.10B |
| AbbVie | 351.30B |
| Abbott Laboratories | 229.85B |
| AstraZeneca | 227.78B |
| Novartis AG | 223.01B |
| UnitedHealth Group | 221.95B |
| Novo Nordisk | 213.92B |